Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical ...
The 2024 report found that the top 25 biotech and top 15 pharmaceutical companies have continued to reduce their annual Scope 1 and 2 carbon intensity by an average of 12% per year since 2018. Even ...
Among the 149 biotech and pharmaceutical companies with high-quality emissions data, 31% have set medium-term Scope 1 and 2 targets (2026–2035) that are aligned with the 1.5°C pathway. However, to ...
Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical ...